Cargando…
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp(™)
Without an approved vaccine or treatment, Ebola outbreak management has been limited to palliative care and barrier methods to prevent transmission. These approaches, however, have yet to end the 2014 outbreak of Ebola after its prolonged presence in West Africa. Here we show that a combination of m...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214273/ https://www.ncbi.nlm.nih.gov/pubmed/25171469 http://dx.doi.org/10.1038/nature13777 |
_version_ | 1782341930051436544 |
---|---|
author | Qiu, Xiangguo Wong, Gary Audet, Jonathan Bello, Alexander Fernando, Lisa Alimonti, Judie B. Fausther-Bovendo, Hugues Wei, Haiyan Aviles, Jenna Hiatt, Ernie Johnson, Ashley Morton, Josh Swope, Kelsi Bohorov, Ognian Bohorova, Natasha Goodman, Charles Kim, Do Pauly, Michael H. Velasco, Jesus Pettitt, James Olinger, Gene G. Whaley, Kevin Xu, Bianli Strong, James E. Zeitlin, Larry Kobinger, Gary P. |
author_facet | Qiu, Xiangguo Wong, Gary Audet, Jonathan Bello, Alexander Fernando, Lisa Alimonti, Judie B. Fausther-Bovendo, Hugues Wei, Haiyan Aviles, Jenna Hiatt, Ernie Johnson, Ashley Morton, Josh Swope, Kelsi Bohorov, Ognian Bohorova, Natasha Goodman, Charles Kim, Do Pauly, Michael H. Velasco, Jesus Pettitt, James Olinger, Gene G. Whaley, Kevin Xu, Bianli Strong, James E. Zeitlin, Larry Kobinger, Gary P. |
author_sort | Qiu, Xiangguo |
collection | PubMed |
description | Without an approved vaccine or treatment, Ebola outbreak management has been limited to palliative care and barrier methods to prevent transmission. These approaches, however, have yet to end the 2014 outbreak of Ebola after its prolonged presence in West Africa. Here we show that a combination of monoclonal antibodies (ZMapp(™)), optimized from two previous antibody cocktails, is able to rescue 100% of rhesus macaques when treatment is initiated up to 5 days post-challenge. High fever, viremia, and abnormalities in blood count and chemistry were evident in many animals before ZMapp(™) intervention. Advanced disease, as indicated by elevated liver enzymes, mucosal hemorrhages and generalized petechia could be reversed, leading to full recovery. ELISA and neutralizing antibody assays indicate that ZMapp(™) is cross-reactive with the Guinean variant of Ebola. ZMapp(™) currently exceeds all previous descriptions of efficacy with other therapeutics, and results warrant further development of this cocktail for clinical use. |
format | Online Article Text |
id | pubmed-4214273 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
record_format | MEDLINE/PubMed |
spelling | pubmed-42142732015-04-02 Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp(™) Qiu, Xiangguo Wong, Gary Audet, Jonathan Bello, Alexander Fernando, Lisa Alimonti, Judie B. Fausther-Bovendo, Hugues Wei, Haiyan Aviles, Jenna Hiatt, Ernie Johnson, Ashley Morton, Josh Swope, Kelsi Bohorov, Ognian Bohorova, Natasha Goodman, Charles Kim, Do Pauly, Michael H. Velasco, Jesus Pettitt, James Olinger, Gene G. Whaley, Kevin Xu, Bianli Strong, James E. Zeitlin, Larry Kobinger, Gary P. Nature Article Without an approved vaccine or treatment, Ebola outbreak management has been limited to palliative care and barrier methods to prevent transmission. These approaches, however, have yet to end the 2014 outbreak of Ebola after its prolonged presence in West Africa. Here we show that a combination of monoclonal antibodies (ZMapp(™)), optimized from two previous antibody cocktails, is able to rescue 100% of rhesus macaques when treatment is initiated up to 5 days post-challenge. High fever, viremia, and abnormalities in blood count and chemistry were evident in many animals before ZMapp(™) intervention. Advanced disease, as indicated by elevated liver enzymes, mucosal hemorrhages and generalized petechia could be reversed, leading to full recovery. ELISA and neutralizing antibody assays indicate that ZMapp(™) is cross-reactive with the Guinean variant of Ebola. ZMapp(™) currently exceeds all previous descriptions of efficacy with other therapeutics, and results warrant further development of this cocktail for clinical use. 2014-08-29 2014-10-02 /pmc/articles/PMC4214273/ /pubmed/25171469 http://dx.doi.org/10.1038/nature13777 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Qiu, Xiangguo Wong, Gary Audet, Jonathan Bello, Alexander Fernando, Lisa Alimonti, Judie B. Fausther-Bovendo, Hugues Wei, Haiyan Aviles, Jenna Hiatt, Ernie Johnson, Ashley Morton, Josh Swope, Kelsi Bohorov, Ognian Bohorova, Natasha Goodman, Charles Kim, Do Pauly, Michael H. Velasco, Jesus Pettitt, James Olinger, Gene G. Whaley, Kevin Xu, Bianli Strong, James E. Zeitlin, Larry Kobinger, Gary P. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp(™) |
title | Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp(™) |
title_full | Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp(™) |
title_fullStr | Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp(™) |
title_full_unstemmed | Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp(™) |
title_short | Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp(™) |
title_sort | reversion of advanced ebola virus disease in nonhuman primates with zmapp(™) |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214273/ https://www.ncbi.nlm.nih.gov/pubmed/25171469 http://dx.doi.org/10.1038/nature13777 |
work_keys_str_mv | AT qiuxiangguo reversionofadvancedebolavirusdiseaseinnonhumanprimateswithzmapp AT wonggary reversionofadvancedebolavirusdiseaseinnonhumanprimateswithzmapp AT audetjonathan reversionofadvancedebolavirusdiseaseinnonhumanprimateswithzmapp AT belloalexander reversionofadvancedebolavirusdiseaseinnonhumanprimateswithzmapp AT fernandolisa reversionofadvancedebolavirusdiseaseinnonhumanprimateswithzmapp AT alimontijudieb reversionofadvancedebolavirusdiseaseinnonhumanprimateswithzmapp AT faustherbovendohugues reversionofadvancedebolavirusdiseaseinnonhumanprimateswithzmapp AT weihaiyan reversionofadvancedebolavirusdiseaseinnonhumanprimateswithzmapp AT avilesjenna reversionofadvancedebolavirusdiseaseinnonhumanprimateswithzmapp AT hiatternie reversionofadvancedebolavirusdiseaseinnonhumanprimateswithzmapp AT johnsonashley reversionofadvancedebolavirusdiseaseinnonhumanprimateswithzmapp AT mortonjosh reversionofadvancedebolavirusdiseaseinnonhumanprimateswithzmapp AT swopekelsi reversionofadvancedebolavirusdiseaseinnonhumanprimateswithzmapp AT bohorovognian reversionofadvancedebolavirusdiseaseinnonhumanprimateswithzmapp AT bohorovanatasha reversionofadvancedebolavirusdiseaseinnonhumanprimateswithzmapp AT goodmancharles reversionofadvancedebolavirusdiseaseinnonhumanprimateswithzmapp AT kimdo reversionofadvancedebolavirusdiseaseinnonhumanprimateswithzmapp AT paulymichaelh reversionofadvancedebolavirusdiseaseinnonhumanprimateswithzmapp AT velascojesus reversionofadvancedebolavirusdiseaseinnonhumanprimateswithzmapp AT pettittjames reversionofadvancedebolavirusdiseaseinnonhumanprimateswithzmapp AT olingergeneg reversionofadvancedebolavirusdiseaseinnonhumanprimateswithzmapp AT whaleykevin reversionofadvancedebolavirusdiseaseinnonhumanprimateswithzmapp AT xubianli reversionofadvancedebolavirusdiseaseinnonhumanprimateswithzmapp AT strongjamese reversionofadvancedebolavirusdiseaseinnonhumanprimateswithzmapp AT zeitlinlarry reversionofadvancedebolavirusdiseaseinnonhumanprimateswithzmapp AT kobingergaryp reversionofadvancedebolavirusdiseaseinnonhumanprimateswithzmapp |